The long term outcome and impact of multidrug-resistant tuberculosis in Henan Province, China
China has the second largest burden of TB cases in the world and its burden of multidrug resistant TB (MDR-TB: resistant to the two principal chemotherapy agents - isoniazid and rifampicin) is also among the highest in the world. Henan, as one of the most populous provinces in China, bears the highest burdens of TB and MDR-TB cases in the country. Multi-drug resistant tuberculosis in Henan, particularly the impact on clinical and socioeconomic outcomes compared to non-MDR-TB, is poorly...[Show more]
|Collections||Open Access Theses|
|b34828989-Sun_Y.pdf||481.35 MB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.